Učitavanje...
CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
OBJECTIVE: To assess the relationship between CD56(bright) natural killer (NK) cells and multiple sclerosis (MS) disease activity in patients with relapsing-remitting MS treated with daclizumab high-yield process (DAC HYP). METHODS: Data were from patients enrolled in a 52-week randomized, double-bl...
Spremljeno u:
| Izdano u: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309527/ https://ncbi.nlm.nih.gov/pubmed/25635261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000065 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|